ICON PLC ICLR

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $163.01
Market Cap $12.84B
P/E Ratio 56.21
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-0.4% YoY
$8.25B
3-Yr CAGR: 2.1%
Net Income ↓-71.0% YoY
$229.34M
Net Margin: 2.8%
Free Cash Flow ↓-22.9% YoY
$861.99M
FCF Yield: 6.72%
EPS (Diluted) ↓-69.6% YoY
$2.90
Basic: $2.92
Return on Equity Efficiency
2.5%
ROA: 217.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ICLR)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1,666.5M $705.2M $262.2M $4.65 $259.2M $216.6M
FY 2017 $1,758.4M +5.5% $731.1M $281.5M +7.4% $5.13 +10.3% $383.1M $338.4M +56.2%
FY 2018 $2,595.8M +47.6% $699.2M $322.7M +14.6% $5.89 +14.8% $268.6M $220.2M -34.9%
FY 2019 $2,805.8M +8.1% $770.2M $374.0M +15.9% $6.79 +15.3% $412.5M $361.9M +64.3%
FY 2020 $2,797.3M -0.3% $817.4M $332.3M -11.1% $6.15 -9.4% $568.0M $517.0M +42.9%
FY 2021 $5,480.8M +95.9% $1,508.2M $153.2M -53.9% $2.25 -63.4% $829.1M $735.4M +42.2%
FY 2022 $7,741.4M +41.2% $2,214.3M $505.3M +229.9% $6.13 +172.4% $563.3M $421.2M -42.7%
FY 2023 $8,120.2M +4.9% $2,400.2M $612.3M +21.2% $7.40 +20.7% $1,161.0M $1,020.3M +142.3%
FY 2024 $8,281.7M +2.0% $2,436.4M $791.5M +29.3% $9.53 +28.8% $1,286.7M $1,118.6M +9.6%
FY 2025 $8,251.3M -0.4% $2,175.6M $229.3M -71.0% $2.90 -69.6% $1,036.2M $862.0M -22.9%
$

Valuation

Market Price $163.01
Market Cap $12.84B
Enterprise Value $15.06B
P/E Ratio 56.21
P/B Ratio 1.36
FCF Yield 6.72%
Dividend Yield N/A
Shares Outstanding 76,601,500
%

Profitability & Margins

Gross Margin 26.37%
Operating Margin 5.37%
Net Margin 2.78%
Return on Equity (ROE) 2.49%
Return on Assets (ROA) 217.76%
Asset Turnover 78.35x
Revenue 3-Yr CAGR 2.15%
🛡️

Financial Health & Liquidity

Current Ratio 0.03
Cash Ratio 0.20
Debt / Equity 0.312
Debt / Assets 27.276
Cash & Equivalents $647.29M
Total Debt $2.87B
Book Value / Share $120.02
💧

Cash Flow Efficiency

Operating Cash Flow $1.04B
Capital Expenditures (CapEx) $174.21M
Free Cash Flow $861.99M
OCF / Revenue 12.56%
FCF / Revenue 10.45%
FCF 3-Yr CAGR 26.97%
🏷️

Per Share Metrics

EPS (Diluted) $2.90
EPS (Basic) $2.92
Dividends / Share N/A
Book Value / Share $120.02
EPS YoY Growth -69.57%
🏛️

Balance Sheet (FY 2025)

Total Assets $105.32M
Total Liabilities $3.20B
Stockholders' Equity $9.19B
Current Assets $105.32M
Current Liabilities $3.20B